Founded in 2001 in the United States, Title21 is an enterprise software company providing solutions to Cell Therapy labs in hospitals. Its main product offerings are Enterprise Quality Management System (EQMS) and Cell Therapy Solutions (BMT / CT): EQMS provides a scalable solution to automate workflows, integrate compliance-driven processes, and enable continuous quality improvement. BMT/CT enables end-to-end electronic management of cellular therapy processes across clinical, manufacturing, and post-infusion followup. Title21 is one of few Cell Therapy software businesses tracking all three supply chains: custody, identity and condition.